Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 3/20 | 0.49 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TOP1 | P11387 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.38 |
| ▸ | CETP | P11597 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31338862 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL17817249 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL12258773 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL9813074 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL13169240 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL789161 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL23016843 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8640646 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL13169239 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL31201935 | 1.00 | GGPS1 (0.49) | GGPS1S1PR2S1PR1S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114796474-A | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114699519-A | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114617959-A | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-108697790-B | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-111601786-A | Branched trialkylamine precursors, intermediates, products made therefrom, and methods of making | 伊士曼化工公司 | 2020-08-28 | — | — | CN | disclosed |
| US-20190218170-A1 | BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE | EASTMAN CHEMICAL COMPANY (US) | 2019-07-18 | — | — | US | disclosed |
| US-9782748-B2 | Synthesis of polymeric ionic liquids using a photochemical polymerization process | THE UNIVERSITY OF TOLEDO (US) | 2017-10-10 | — | — | US | disclosed |
| US-20150119231-A1 | Synthesis of Polymeric Ionic Liquids Using a Photochemical Polymerization Process | THE UNIVERSITY OF TOLEDO (US) | 2015-04-30 | — | — | US | disclosed |
| US-8734673-B2 | Boron selective ionic liquids and polymeric ionic liquids, methods of making and methods of use thereof | THE UNIVERSITY OF TOLEDO (US) | 2014-05-27 | — | — | US | disclosed |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218170-A1 | BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE | ACADM, ALK, FASN | GGPS1 1291/4885S1PR2 595/4885S1PR1 499/4885 |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | BCCIP, SLC6A12, BOLA2; BOLA2B | GGPS1 3813/4885S1PR2 1694/4885S1PR1 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.